INVESTOR RELATIONS

Press Releases
May 26, 2021

Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its cardiac radioablation (CRA)...

Apr 27, 2021

Varian, a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the...

Apr 12, 2021

Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the...

Apr 8, 2021

Varian (NYSE: VAR) today announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and...

View all press releases

Past Events
Tuesday, January 26, 2021
1:10pm PST

In light of the pending transaction with Siemens Healthineers, Varian will not be hosting a conference call for its first quarter of fiscal year 2021 earnings.

Tuesday, October 27, 2020
2:15pm PDT

In light of the pending transaction with Siemens Healthineers, Varian will not be hosting a conference call for its fourth quarter of fiscal year 2020 earnings.

Thursday, October 15, 2020
9:00am PDT
Wednesday, August 5, 2020
1:30pm PDT

Canceled Third Quarter Conference Call in Light of Pending Transaction with Siemens Healthineers

View more events

Quarterly Results
Contact Info

Siemens Healthineers Investor Relations

For questions about physical certificates you possess or shares you hold in electronic form with Computershare:

Computershare
Transfer Agent
1 (800) 756-8200 or
1 (781) 575-2879
https://www-us.computershare.com/investor/
 

For questions regarding your UBS holdings:

UBS
Stock Plan Administrator
1 (877) 752-8276
1 (201) 272-7623
VMSstockPlans@ubs.com or
StockAdmin@varian.com